rs25714
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002024.6(FMR1):c.990+14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 1,016,839 control chromosomes in the GnomAD database, including 8,332 homozygotes. There are 32,742 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1085 hom., 3999 hem., cov: 23)
Exomes 𝑓: 0.10 ( 7247 hom. 28743 hem. )
Consequence
FMR1
NM_002024.6 intron
NM_002024.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.190
Genes affected
FMR1 (HGNC:3775): (fragile X messenger ribonucleoprotein 1) The protein encoded by this gene binds RNA and is associated with polysomes. The encoded protein may be involved in mRNA trafficking from the nucleus to the cytoplasm. A trinucleotide repeat (CGG) in the 5' UTR is normally found at 6-53 copies, but an expansion to 55-230 repeats is the cause of fragile X syndrome. Expansion of the trinucleotide repeat may also cause one form of premature ovarian failure (POF1). Multiple alternatively spliced transcript variants that encode different protein isoforms and which are located in different cellular locations have been described for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-147936627-C-T is Benign according to our data. Variant chrX-147936627-C-T is described in ClinVar as [Benign]. Clinvar id is 94025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-147936627-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.682 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMR1 | NM_002024.6 | c.990+14C>T | intron_variant | ENST00000370475.9 | NP_002015.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMR1 | ENST00000370475.9 | c.990+14C>T | intron_variant | 1 | NM_002024.6 | ENSP00000359506 | P3 |
Frequencies
GnomAD3 genomes AF: 0.121 AC: 13402AN: 110776Hom.: 1088 Cov.: 23 AF XY: 0.121 AC XY: 3997AN XY: 33078
GnomAD3 genomes
AF:
AC:
13402
AN:
110776
Hom.:
Cov.:
23
AF XY:
AC XY:
3997
AN XY:
33078
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.161 AC: 29106AN: 181043Hom.: 3566 AF XY: 0.144 AC XY: 9501AN XY: 65759
GnomAD3 exomes
AF:
AC:
29106
AN:
181043
Hom.:
AF XY:
AC XY:
9501
AN XY:
65759
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.102 AC: 92357AN: 906012Hom.: 7247 Cov.: 18 AF XY: 0.114 AC XY: 28743AN XY: 253082
GnomAD4 exome
AF:
AC:
92357
AN:
906012
Hom.:
Cov.:
18
AF XY:
AC XY:
28743
AN XY:
253082
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.121 AC: 13402AN: 110827Hom.: 1085 Cov.: 23 AF XY: 0.121 AC XY: 3999AN XY: 33139
GnomAD4 genome
AF:
AC:
13402
AN:
110827
Hom.:
Cov.:
23
AF XY:
AC XY:
3999
AN XY:
33139
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 29, 2017 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Fragile X syndrome Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at